APA (7th ed.) Citation

NG, H., MS, L., R, K., MR, B., K, M., A, S., . . . A, E. (2021). Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target. Frontiers in oncology, 11, 783744. https://doi.org/10.3389/fonc.2021.783744

Chicago Style (17th ed.) Citation

NG, Holtzman, Lebowitz MS, Koka R, Baer MR, Malhotra K, Shahlaee A, Ghanbari HA, Bentzen SM, and Emadi A. "Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target." Frontiers in Oncology 11 (2021): 783744. https://doi.org/10.3389/fonc.2021.783744.

MLA (9th ed.) Citation

NG, Holtzman, et al. "Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target." Frontiers in Oncology, vol. 11, 2021, p. 783744, https://doi.org/10.3389/fonc.2021.783744.